Catalyst Wire Dossier Catalyst Wire Dossier

VPM1002

recombinant Bacillus Calmette-Guérin vaccine (rBCG) · Serum Institute of India Pvt. Ltd.
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for VPM1002, covering 2010-05-20 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic [Phase 3]

See pricing